Mohamed Sikkander Abdul Razak/LinkedIn
Apr 6, 2026, 10:03
Mohamed Sikkander Abdul Razak: Clinical Steps for Evaluating and Managing Heavy Menstrual Bleeding
Mohamed Sikkander Abdul Razak, Professor at GKM College of Engineering Technology, shared a post on LinkedIn:
“Clinical steps for evaluating and managing heavy menstrual bleeding (HMB):
1. Initial assessment:
- Detailed history (menstrual pattern, bleeding severity, iron deficiency, family history of bleeding disorders).
- Physical exam to rule out structural causes (e.g., fibroids).
2.Laboratory evaluation:
- Complete blood count (CBC) to check for anemia.
- Iron studies (serum ferritin, iron levels).
- Coagulation screening: PT, aPTT, von Willebrand factor (vWF) antigen/activity, platelet function tests.
3. Identify underlying hemostatic defect:
- Confirm vWD or platelet dysfunction (most common causes).
- Assess for factor deficiencies if indicated.
4.Management strategies:
Medical therapy:
- Hormonal treatments (combined oral contraceptives, levonorgestrel IUS) to regulate cycles and reduce bleeding.
- Antifibrinolytics (tranexamic acid) during menses to stabilize clots.
Hemostatic therapy:
- vWF concentrates or DDAVP for vWD.
- Platelet transfusions or specific factor replacement if needed.
Surgical options:
- Endometrial ablation or hysterectomy in refractory cases.
5. Pregnancy planning:
- Preconception counseling and hemostatic optimization to prevent miscarriage or postpartum hemorrhage.
- Specialist referral for individualized risk assessment.
6.Follow‑up:
- Monitor hemoglobin and iron levels.
- Re‑evaluate hemostatic workup if bleeding persists or complications arise.”

Find more posts featuring Mohamed Sikkander Abdul Razak on Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series